With the goal of translating MRA use for the earlier onset skeletal muscle pathology in DMD, we have been defining the mechanisms of MR function in mouse skeletal muscles using a combination of pharmacological and genetic approaches. Here, NR3C2 is linked to Duchenne muscular dystrophy.